Trials / Completed
CompletedNCT02994446
Saline-Enhanced Radiofrequency (SERF) Catheter Ablation for the Treatment of Ventricular Tachycardia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Thermedical, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to demonstrate the technical feasibility of the SERF Catheter and SERF Cardiac Ablation System to eliminate or control ventricular tachycardia (VT)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Saline-Enhanced Radiofrequency Catheter and Ablation System | Ablation of ventricular tachycardia with a saline-enhanced radiofrequency ablation catheter |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2021-04-21
- Completion
- 2021-10-04
- First posted
- 2016-12-15
- Last updated
- 2022-04-28
Locations
3 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT02994446. Inclusion in this directory is not an endorsement.